The latest medical study has shown that getting inflicted with COVID-19 is like getting bitten by a poisonous rattlesnake.
Researchers from various universities including the Stony Brook University on Long Island have identified an enzyme in the coronavirus that ravages the body like the neurotoxins from rattlesnake venom.
The researchers said to save the lives of COVID-19 patients it is better to target the enzyme, which causes severe inflammation.
They said the coronavirus enzyme, sPLA2-II, has similarities to an active enzyme in rattlesnake venom that is typically found in low concentrations in healthy individuals and has long been known to play a critical role in humans’ defense against bacterial infections.
They added that when the same enzyme circulates at high levels, it can “shred” the membranes of vital organs.
Moreover, the researchers recommend a new therapeutic target to reduce or even prevent COVID-19 mortality.
To get their data the researchers contacted Stony Brook to analyze blood samples in COVID-19 patients to study the snake venom-type enzyme.
The researchers then collected stored blood plasma samples and analyzed medical charts from 127 patients hospitalized at Stony Brook University Hospital between January and July 2020.
A collection of 154 patient samples from Stony Brook and Banner University Medical Center in Tucson between January and November 2020 also were examined.
It was learned there are already 634,157 people killed by the coronavirus throughout the United States.